{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T12:42:28Z","timestamp":1769344948567,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T00:00:00Z","timestamp":1460160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.nefro.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T04:20:11Z","timestamp":1464668411000},"page":"418-426","source":"Crossref","is-referenced-by-count":7,"title":["Trece tratamientos de la insuficiencia renal aguda secundaria a mieloma m\u00faltiple con filtros de high cut off"],"prefix":"10.1016","volume":"36","author":[{"given":"Ana","family":"Berni Wennekers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Pilar","family":"Mart\u00edn Azara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Dourdil Sahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Bergasa Liberal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Esteban","family":"Ruiz Laiglesia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Vernet Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Alvarez Lipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2016.03.011_bib0175","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1016\/j.nefro.2016.03.011_bib0180","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Eng J Med"},{"key":"10.1016\/j.nefro.2016.03.011_bib0185","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1093\/ndt\/gfs449","article-title":"Myeloma kidney: Advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities","volume":"27","author":"Davenport","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2016.03.011_bib0190","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2016.03.011_bib0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnoses multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nefro.2016.03.011_bib0200","first-page":"131","article-title":"Supervivencia de pacientes con mieloma tratados con di\u00e1lisis","volume":"XXIII","author":"Mart\u00edn Reyes","year":"2003","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2016.03.011_bib0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/ehm.11.72","article-title":"Management of myeloma-associated renal dysfunction in the era of novel therapies","volume":"5","author":"Gaballa","year":"2012","journal-title":"Expert Rec Hematol"},{"key":"10.1016\/j.nefro.2016.03.011_bib0210","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: The disease spectrum","volume":"12","author":"Lin","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2016.03.011_bib0215","first-page":"986","article-title":"Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence-Jones cast nephropathy in a necropsy study of patients with myeloma","volume":"114","author":"Ivany","year":"1990","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.nefro.2016.03.011_bib0220","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1200\/JCO.2009.22.2232","article-title":"VMP (bortezomib, melphalan, and prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: Cohort analysis of the phase III VISTA study","volume":"27","author":"Dimopoulos","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nefro.2016.03.011_bib0225","first-page":"1443","article-title":"Pomalidomide for the management of refractory multiple myeloma","volume":"71","author":"Summers","year":"2014","journal-title":"Am J Health"},{"issue":"ext","key":"10.1016\/j.nefro.2016.03.011_bib0230","first-page":"63","article-title":"Nuevos Avances en el tratamiento del mieloma m\u00faltiple","volume":"18","author":"Ocio","year":"2014","journal-title":"Hematolog\u00eda"},{"issue":"15 suppl","key":"10.1016\/j.nefro.2016.03.011_bib0235","first-page":"8532","article-title":"A phase I trial of SAR650984, a CD38 monoclonal antibody, in relapsed or refractory multiple myeloma","volume":"32","author":"Martin","year":"2014","journal-title":"ASCO Meeting Abstracts"},{"issue":"15 suppl","key":"10.1016\/j.nefro.2016.03.011_bib0240","first-page":"8513","article-title":"Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM)","volume":"32","author":"Lokhorst","year":"2014","journal-title":"ASCO Meeting Abstracts"},{"key":"10.1016\/j.nefro.2016.03.011_bib0245","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2215\/CJN.04590908","article-title":"Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off haemodialysis","volume":"4","author":"Hutchison","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2016.03.011_bib0250","doi-asserted-by":"crossref","first-page":"773","DOI":"10.7326\/0003-4819-143-11-200512060-00005","article-title":"Plasma exchange when myeloma presents as acute renal failure","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefro.2016.03.011_bib0255","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1056\/NEJMc1101834","article-title":"Renal improvement in myeloma with bortezomib plus plasma exchange","volume":"364","author":"Burnette","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2016.03.011_bib0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000316684","article-title":"Reduction of free inmunoglobulin light chains using adsorption properties of hemodiafiltration with endogenous reinfusion","volume":"30","author":"Testa","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.nefro.2016.03.011_bib0265","first-page":"788","article-title":"Eficacia de la hemodiafiltraci\u00f3n con regeneraci\u00f3n del ultrafiltrado en la reducci\u00f3n de las cadenas ligeras en el mieloma m\u00faltiple con insuficiencia renal","volume":"33","author":"Pend\u00f3n Ruiz","year":"2013","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2016.03.011_bib0270","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1681\/ASN.2010080857","article-title":"Early reduction of serum-free light chains associates with renal recovery in myeloma multiple","volume":"22","author":"Hutchison","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2016.03.011_bib0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4321\/S2254-28842014000200008","article-title":"El fracaso renal agudo por mieloma m\u00faltiple: cuidados de los pacientes en una unidad de hemodi\u00e1lisis","volume":"17","author":"Cant\u00edn Lahoz","year":"2014","journal-title":"Enferm Nefrol"},{"key":"10.1016\/j.nefro.2016.03.011_bib0280","first-page":"35","article-title":"Tratamiento con hemodi\u00e1lisis del fracaso renal agudo en el mieloma m\u00faltiple con filtros de alto poro (high cut off)","volume":"32","author":"Mart\u00edn Reyes","year":"2012","journal-title":"Nefrol"},{"key":"10.1016\/j.nefro.2016.03.011_bib0285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.ackd.2012.06.003","article-title":"The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney","volume":"19","author":"Cockwell","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.nefro.2016.03.011_bib0290","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/ndt\/gfr773","article-title":"Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis","volume":"27","author":"Hutchison","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2016.03.011_bib0295","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.ajkd.2011.12.028","article-title":"Clinicopathologic correlations in multiple myeloma: A case series of 190 patients with kidney biopsies","volume":"59","author":"Nasr","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2016.03.011_bib0300","first-page":"443","article-title":"Nuevas alternativas en el tratamiento del ri\u00f1\u00f3n del mieloma","volume":"33","author":"\u00c1lvarez de Lara","year":"2013","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2016.03.011_bib0305","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1990.00390160111022","article-title":"Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy","volume":"150","author":"Johnson","year":"1990","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.nefro.2016.03.011_bib0310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/2047-783X-14-2-47","article-title":"Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy","volume":"14","author":"Kleeberg","year":"2009","journal-title":"Eur J Med Res."},{"key":"10.1016\/j.nefro.2016.03.011_bib0315","first-page":"515","article-title":"Tratamiento con hemodi\u00e1lisis larga con filtros de alto cut-off en la nefropat\u00eda por cilindros del mieloma: nuestra experiencia","volume":"33","author":"Borrego","year":"2013","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2016.03.011_bib0320","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ajh.23189","article-title":"High cut-off haemodialysis and bortezomib-based therapy to rescue kidneys in myeloma-dependent cast nephropathy","volume":"87","author":"Sinisalo","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nefro.2016.03.011_bib0325","unstructured":"Echabe L, Iturralde I, Gonz\u00e1lez E, Telleria A, Rodrigo T, Rivas M. Hemodi\u00e1lisis con filtro de alta permeabilidad para eliminaci\u00f3n de cadenas ligeras en pacientes con mieloma. [consultado 24 Abr 2013]. Disponible en: http:\/\/www.revistaseden.org\/files\/2736_23 1620.pdf"},{"issue":"Sup. 3","key":"10.1016\/j.nefro.2016.03.011_bib0330","first-page":"112","article-title":"Hemodi\u00e1lisis con membrana de alto poro en el fracaso renal agudo por cadenas ligeras del mieloma m\u00faltiple: resultados a 3 a\u00f1os de un estudio protocolizado en un centro","volume":"32","author":"Mu\u00f1oz","year":"2012","journal-title":"Nefrolog\u00eda."},{"key":"10.1016\/j.nefro.2016.03.011_bib0335","first-page":"132","article-title":"Hemodi\u00e1lisis con dializadores de poro grueso para tratar el fracaso renal agudo del paciente con mieloma","volume":"14","author":"Mallol","year":"2011","journal-title":"Rev Soc Esp Enferm Nefrol"},{"key":"10.1016\/j.nefro.2016.03.011_bib0340","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1185\/03007995.2010.543125","article-title":"Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney","volume":"27","author":"Grima","year":"2011","journal-title":"Curr Med Res Opin"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699516300145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699516300145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T21:27:05Z","timestamp":1656624425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699516300145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0211699516300145"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2016.03.011","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}